"Designing Growth Strategies is in our DNA"

Colorectal Cancer Screening Market Size, Share and Global Trend By Test Type (Stool-based tests, Colonoscopy, CT Colonography, Flexible Sigmoidoscopy, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centres, Diagnostic Centers, Others) and Geography Forecast till 2026

Region : Global | Report ID: FBI101144 | Status : Ongoing

 

KEY MARKET INSIGHTS

Colon cancer refers to cancer in the large intestine (colon), a part of the alimentary canal. Most of the colon cancer cases begin as noncancerous (benign) small clumps of cells, which are called adenomatous polyps. In the due curse of time, some of these adenomatous polyps can become colon cancers. Symptoms of colorectal cancer include alteration in bowel habits, leading to constipation or diarrhea or a change in the constancy of the stool, rectal blood or bleeding in the stool, constant abdominal discomfort, such as pain, gas or cramps, and others.


Rising prevalence has increased the need for effective diagnostic techniques for colorectal cancer. The emergence for molecular diagnosis, in-vitro diagnosis, and cytogenetics have also enhanced the tools for the detection of colorectal cancer. Furthermore, government and private awareness programs encouraging early detection and colonoscopies are expected to surge the global colorectal cancer screening market.


To gain extensive insights into the market, Request for Customization


 


For example, in March 2019, Olympus Corporation announced the company’s support in for “National Colorectal Cancer (CRC) Awareness” through sponsoring certain colonoscopies, sponsoring Colorectal Cancer Alliances' "Big Colon Tour," and many others.


Increase in the prevalence of colorectal cancer, rapid adoption of molecular diagnostics techniques, and emerging colorectal cancer diagnosis guidelines is driving the growth in the global colorectal cancer screening market. According to The World Cancer Research Fund, colorectal cancer is the third most common cancer in the world, with 1.8 million cases in 2018, which is expected to fuel the colorectal cancer screening market.


Also, initiatives taken by the government and private organizations for the increasing awareness about the screening and most effective treatment methods for the colorectal cancer is expected to further drive the growth in the global colorectal cancer screening market.


However, the high cost of the diagnosis tests and inadequate healthcare access in developing countries are the major factors that can inhibit the growth in the global colorectal cancer screening market.


Key Players Covered


Some of the major companies that are present in the colorectal cancer screening market are Alere INC, Clinical Genomics, Beckman Coulter, Abbott, Exact Sciences Corp., Sysmex Corporation, Hemosure, Quidel Corporation, Eiken Chemical, Novigenix SA, Epigenomics AG, and others.


SEGMENTATION






















SEGMENTATION


 DETAILS

By Test Type



· Stool-based tests


· Colonoscopy


· CT Colonography


· Flexible Sigmoidoscopy


· Others



By End User



· Hospitals


· Specialty Clinics


· Ambulatory Surgery Centres


· Diagnostic Centers


· Others



By Geography



· North America (USA and Canada)


· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)


· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)


· Latin America (Brazil, Mexico and Rest of Latin America)


· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



 


Among the test type, stool-based tests segment is projected to hold a considerable share of the global colorectal cancer screening market during the forecast duration as it is used as a primary screening test for colorectal cancer screening, comparatively less expensive, and easy for patients as sampling can be done at home.


Key Insights



  • Prevalence of colorectal cancer for key countries

  • The regulatory scenario for key countries

  • Reimbursement scenario for key countries

  • Colorectal cancer diagnosis guidelines overview

  • New product launch

  • Recent industry developments such as partnerships, mergers, and acquisitions


Regional Analysis


North America is projected to dominate the global colorectal cancer screening market over the forecast period owing to the emerging government guideline for diagnosis and increasing demand for molecular diagnosis techniques. According to the American Cancer Society, approximately 101,420 new cases of colon cancer and 44,180 new cases of rectal cancer are expected to be diagnosed in 2019 in the U.S., which is anticipated to favor the colorectal cancer screening market. Asia Pacific is estimated to report a remarkable growth in the colorectal cancer screening market in the forecast period due to the rising awareness regarding colorectal cancer, increasing patient pool of colorectal cancer, and high investment in the research and development.


Key Industry Developments



  • In March 2019, Olympus Corporation announced the company’s support for “National Colorectal Cancer (CRC) Awareness” through sponsoring certain colonoscopies, sponsoring Colorectal Cancer Alliances' "Big Colon Tour", and many others.

  • In October 2018, Metabolomic Technologies Inc. launched worth $1.4 Mn project for the evaluation of screening strategy for colorectal cancer using PolypDx, a urine test for the prevention and diagnosis of colorectal cancer.

  • In August 2018, Exact Sciences Corporation partnered with Pfizer Inc., for the co-promotion of COLOGUARD, a non-invasive FDA approved stool DNA test for detection of colorectal cancer.

  • In February 2015, Novigenix SA acquired a molecular-based blood test for colorectal cancer named Colox Test from Diagnoplex SA for the expansion of Colox in Switzerland and rest of Europe.


Colorectal Cancer Screening Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2019
  • 2016-2018

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

SUANFARMA
Intuitive_Surgical_logo
Logo_Merck_KGaA_2015
Natus-Medical
Abbott

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X